Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Side effect of metenolone enanthate on rats heart in puberty: morphometrical study.

Ozdemir O, Bozkurt I, Ozdemir M, Yavuz O.

Exp Toxicol Pathol. 2013 Sep;65(6):745-50. doi: 10.1016/j.etp.2012.09.009. Epub 2012 Dec 29.

PMID:
23280519
2.
3.

Effects of chronic adenosine uptake blockade on adrenergic responsiveness and left ventricular chamber function in pressure overload hypertrophy in the rat.

Chung ES, Perlini S, Aurigemma GP, Fenton RA, Dobson JG Jr, Meyer TE.

J Hypertens. 1998 Dec;16(12 Pt 1):1813-22.

PMID:
9869016
4.

Spironolactone effects on myocardium changes induced by thyroid hormone in rats.

Fernandes ML, Ferro EA, Beletti ME, Resende ES.

Arq Bras Cardiol. 2007 Dec;89(6):398-402. English, Portuguese.

5.

Cardiac hypertrophy in deceased users of anabolic androgenic steroids: an investigation of autopsy findings.

Far HR, Ågren G, Thiblin I.

Cardiovasc Pathol. 2012 Jul-Aug;21(4):312-6. doi: 10.1016/j.carpath.2011.10.002. Epub 2011 Nov 21.

PMID:
22104006
7.
8.

Coronary vessel alterations following chronic carbon monoxide exposure in the adult rat.

Penney DG, Giraldo AA, Van Egmond EM.

J Appl Toxicol. 1994 Jan-Feb;14(1):47-54.

PMID:
8157870
9.

An androgenic steroid decreases left ventricular compliance in rats.

Trifunovic B, Norton GR, Duffield MJ, Avraam P, Woodiwiss AJ.

Am J Physiol. 1995 Mar;268(3 Pt 2):H1096-105.

PMID:
7900863
11.

Heart rate variability and left ventricular mass in slim children and young adults with hypertension.

Kowalewski M, Baszuk-Stefaniuk E, Urban M, Peczyńska J.

Kardiol Pol. 2005 Dec;63(6):605-10; discussion 611-2.

PMID:
16380859
12.

Comparison between maximal left ventricular wall thickness and left ventricular mass in patients with hypertrophic cardiomyopathy.

Spiewak M, Chojnowska L, Małek LA, Miłosz B, Petryka J, Zabicka M, Kłopotowski M, Dabrowski M, Miśko J, Ruzyłło W.

Kardiol Pol. 2010 Jul;68(7):763-8.

14.

Relation between QRS amplitude and left ventricular mass in the initial stage of exercise-induced left ventricular hypertrophy in rats.

Bacharova L, Michalak K, Kyselovic J, Klimas J.

Clin Exp Hypertens. 2005 Aug;27(6):533-41.

PMID:
16081345
15.

Regression of cardiac hypertrophy normalizes glucose metabolism and left ventricular function during reperfusion.

Wambolt RB, Henning SL, English DR, Bondy GP, Allard MF.

J Mol Cell Cardiol. 1997 Mar;29(3):939-48.

PMID:
9152855
16.

Ghrelin PYY 3-36 serum changes in left ventricular hypertrophic, insulin-resistant, hypertensive obese patients.

Karcz-Socha I, Zwirska-Korczala K, Zembala M, Borgiel-Marek H, Karcz K.

Obes Facts. 2011;4(5):386-92. doi: 10.1159/000334198. Epub 2011 Oct 21.

17.

Discrepancy between increased left ventricular mass and "normal" QRS voltage is associated with decreased connexin 43 expression in early stage of left ventricular hypertrophy in spontaneously hypertensive rats.

Bacharova L, Plandorova J, Klimas J, Krenek P, Kyselovic J.

J Electrocardiol. 2008 Nov-Dec;41(6):730-4. doi: 10.1016/j.jelectrocard.2008.01.013. Epub 2008 Mar 20.

PMID:
18358486
18.

Differential effects of angiotensin II receptor blockade on pressure-induced left ventricular hypertrophy and fibrosis in rats.

Baba HA, Iwai T, Bauer M, Irlbeck M, Schmid KW, Zimmer HG.

J Mol Cell Cardiol. 1999 Feb;31(2):445-55.

PMID:
10093056
20.

Effects of AT1 receptor block begun late in life on normal cardiac aging in rats.

Saupe KW, Sobol SC, Koh SG, Apstein CS.

J Cardiovasc Pharmacol. 2003 Oct;42(4):573-80.

PMID:
14508245

Supplemental Content

Support Center